Europe Histopathology Services Market Expected to Reach $8,766 million by 2023

The adoption of histopathology services is expected to increase in the near future, owing to rise in prevalence of infectious diseases and cancer in the European region. Moreover, surge in demand for personalized medicine propels the market growth. The histopathology services market has gained traction among healthcare providers, as these tests help to diagnose a disease, stage or extent of a malignant disease, and identify the presence of unsuspected concurrent diseases. Moreover, these tests can be used to provide information for postoperative treatment in certain surgical procedures. In addition, rapid surge in geriatric population in Europe is anticipated to drive the market growth.

Download PDF @ http://bit.ly/2xd0ycs

Histopathology is a branch of pathology, which deals with the study of changes in tissue occurring due to a disease. In this procedure, suspected tissues (for a disease) are removed from a patient's body and examined in a laboratory to study manifestations of the disease.

Increase in prevalence of cancer & other chronic disorders, rapid growth in geriatric population in Europe, and rise in public awareness towards disease screening drive the growth of the Europe histopathology services market. However, limitations of histopathology, as the technique is subjected to human error during analysis and preparation of tissue slides, and dearth of pathologists & medical laboratory scientists in the UK are expected to impede the market growth. On the contrary, increase in demand for personalized medicine is expected to offer ample opportunities for market expansion during the forecast period.

The surgical specimen segment accounted for nearly half of the market share in 2016, and is expected to maintain its dominant position during the analysis period, owing to increase in number of surgical procedures across Europe.

Key Findings of the Europe Histopathology Services Market :

- The liver biopsy segment is expected to grow at a CAGR of 9.9% from 2017 to 2023.

- UK is expected to grow at the highest CAGR of 7.4%.

- Germany held a major share of 19.6% in 2016 in the European market, and is expected to retain its position throughout the forecast period.

- Gastrointestinal biopsy segment held a share of 11.6% in 2016.

Get More Information @ https://www.alliedmarketresearch.com/europe-histopathology-lab-market

The list of key players profiled in this report include Acculabs Diagnostics UK Ltd., Cellular Pathology Services Limited, Great Ormond Street Hospital (GOSH) Laboratory, HCA Laboratories UK, Laboratoire Cerba, Sonic Healthcare Limited, Spire Healthcare Group Plc, Targos Molecular Pathology GmbH, TPL Path Labs, and Unilabs Group Services.

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.